В России представлено лекарство от коронавируса
Федеральное медико-биологическое агентство (ФМБА) представило препарат по лечению нового коронавируса, сообщила пресс-служба агентства.
Для тех, кто не потерял способность думать: "According to investigators, adding hydroxychloroquine (HCQ), a more tolerable form of chloroquine, on top of conventional therapy didn’t shorten the time to SARS-CoV-2 clearance in a 30-patient trial. No significant differences were observed across the two arms in terms of the time it took to bring body temperature to normal or the number of patients with disease progression as shown in CT scans.
In a separate, retrospective study published in the Chinese Journal of Infectious Diseases on 134 patients conducted by several members of the same team, researchers reported that both Kaletra patients and Arbidol patients restored normal temperature after a median of six days, while those who got no antiviral med saw their temperatures drop after four days."
In a separate, retrospective study published in the Chinese Journal of Infectious Diseases on 134 patients conducted by several members of the same team, researchers reported that both Kaletra patients and Arbidol patients restored normal temperature after a median of six days, while those who got no antiviral med saw their temperatures drop after four days."
Нравится
В избранное
Цитировать
подробнее
подробнее